Get started
TRYPTAMINE THERAPEUTICS LIMITEDTRYPTAMINE THERAPEUTICS LIMITEDTRYPTAMINE THERAPEUTICS LIMITED

TRYPTAMINE THERAPEUTICS LIMITED

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

TYP chart


Full chart

Key stats


Market capitalization
‪46.05 M‬ AUD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.008 AUD
Net income (FY)
‪−6.14 M‬ AUD
Revenue (FY)
0.00 AUD
Shares float
‪1.28 B‬
Beta (1Y)
1.41

About TRYPTAMINE THERAPEUTICS LIMITED


Sector
Commercial Services
Industry
Miscellaneous Commercial Services
CEO
Jason Alan Carroll
Website
tryptherapeutics.com
Headquarters
Camberwell
ISIN
AU0000331993
FIGI
BBG00MJ66TB5
Tryptamine Therapeutics Ltd. is a clinical-stage biotechnology company, which engages in investing in biopharmaceutical drug development. The company was headquartered in Camberwell, Australia.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

TYP news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as TYP.

Frequently Asked Questions


The current price of TYP is 0.032 AUD — it has decreased by −5.88% in the past 24 hours. Watch TRYPTAMINE THERAPEUTICS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange TRYPTAMINE THERAPEUTICS LIMITED stocks are traded under the ticker TYP.
TYP stock has fallen by −11.11% compared to the previous week, the month change is a −8.57% fall, over the last year TRYPTAMINE THERAPEUTICS LIMITED has showed a 23.08% increase.
TYP reached its all-time high on Nov 13, 2024 with the price of 0.057 AUD, and its all-time low was 0.017 AUD and was reached on Oct 2, 2024. View more price dynamics on TYP chart.
See other stocks reaching their highest and lowest prices.
TYP stock is 6.25% volatile and has beta coefficient of 1.41. Track TRYPTAMINE THERAPEUTICS LIMITED stock price on the chart and check out the list of the most volatile stocks — is TRYPTAMINE THERAPEUTICS LIMITED there?
Today TRYPTAMINE THERAPEUTICS LIMITED has the market capitalization of ‪46.05 M‬, it has increased by 6.45% over the last week.
Yes, you can track TRYPTAMINE THERAPEUTICS LIMITED financials in yearly and quarterly reports right on TradingView.
TYP net income for the last half-year is ‪−4.03 M‬ AUD, while the previous report showed ‪−9.87 M‬ AUD of net income which accounts for 59.20% change. Track more TRYPTAMINE THERAPEUTICS LIMITED financial stats to get the full picture.
No, TYP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, TYP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade TRYPTAMINE THERAPEUTICS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So TRYPTAMINE THERAPEUTICS LIMITED technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating TRYPTAMINE THERAPEUTICS LIMITED stock shows the sell signal. See more of TRYPTAMINE THERAPEUTICS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.